Related Experiment Video
Updated: Aug 13, 2025
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.8K
Selenium-Containing Agents Acting on Cancer-A New Hope?
Sabrina Garbo1, Silvia Di Giacomo2, Dorota Łażewska3
1Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
Pharmaceutics
|January 21, 2023
Summary
Selenium agents show promise for cancer therapy, with recent research focusing on small molecules and nanoparticles. Despite advancements, most selenium agents haven't reached clinical trials for cancer treatment.
Area of Science:
- Oncology
- Chemistry
- Nanotechnology
Background:
- Selenium-containing agents are increasingly recognized for their innovative potential in cancer treatment.
- Significant progress has been made in understanding the complex biology and chemistry of selenium small molecules and nanoparticles.
- Research explores their roles in tumor development, metastasis, drug delivery, multidrug resistance, and immune modulation.
Purpose of the Study:
- To critically review the current advancements in developing potent, target-specific selenium-containing agents for cancer therapy.
- To provide an overview of selenium's role in various aspects of cancer treatment.
Main Methods:
- Literature review of recent studies on selenium-containing agents in cancer therapy.
- Analysis of biological and chemical properties of selenium compounds and nanoparticles.
- Evaluation of their therapeutic potential and limitations.
Main Results:
- Numerous selenium agents have been investigated for their anti-cancer effects.
- Despite extensive research, only selenocysteine and selenomethionine have progressed towards clinical applications.
- Challenges remain in translating promising selenium agents into clinical trials.
Conclusions:
- Selenium-containing agents, including nanoparticles, represent a promising frontier in cancer therapy.
- Further research is needed to overcome barriers and advance these agents into clinical trials.
- Development of highly potent, target-specific selenium agents is crucial for future cancer treatment strategies.
Related Concept Videos
02:59Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K